Bring life-changing innovations to market, faster.
We believe human ingenuity can change the world.
And inspiration can be sparked by the smallest moments and set the lifecycle of innovation into motion. Watch the video to see how a bold idea becomes a life-changing innovation, with a little help from Clarivate.
The lifecycle of innovation.
Every product we use, medical treatment we receive and service we consume has been imagined, created and improved in a continuous, connected cycle of innovation.
Clarivate operates at the heart of that lifecycle. We give our customers the lens of clarity—the insights they need to turn bold ideas into life-changing innovations.
- Discover. Find new insights, connecting the dots through the most trusted content and analytics.
- Protect. Design brands and protect inventions using the world’s leading sources of information and technology.
- Commercialize. Maximize return on investment and successfully enter new markets using unique services, tools and insights.
Our expert analysts explore game-changers and trends across the innovation lifecycle.
The 2020 Trademark Ecosystem
In our recent survey, 85% of brands experienced trademark infringement in the past year, showing a steady upward trend. Three quarters of trademark infringements also led to litigation. Read the report.
Highly Cited Researchers
We recognize the world’s most influential researchers, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year in Web of Science. See who made the list.
Derwent Top 100 Global Innovators™ 2020
Our annual analysis points to a tougher innovation ecosystem than ever before with shrinking market share, compression at the top and an increased need for collaboration.
It starts with an idea.
Meet the trailblazers who are setting innovation into motion.
Clarivate is a global leader in providing trusted insights and analytics to accelerate the pace of innovation. Our vision is to improve the way the world creates, protects and advances innovation.
SOURCE: Pharma europe http://ip-science.thomsonreuters.com/pharma/integrity_whatsnew/poll.html Pharma europe